«T-Lymphocytes

Below is an extended T-Lymphocytes patents listing. Click here to return to the T-Lymphocytes main in depth entry.

Patents :
US Patent No.	Title
7396681	Application of Hsp70 proteins
7402307	Method for identifying and killing cancer cells
7402314	In vivo activation of tumor-specific cytotoxic T cells
7402322	Methods of treatment for septic shock with urine extract
7402401	Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof
7404950	Induced activation in dendritic cell
7404957	Modified IL-4 mutein receptor antagonists
7405047	Method for estimation of the amount of specific cell types
7405229	Cathepsin cysteine protease inhibitors
7405279	Chimeric proteins for diagnosis and treatment of diabetes
7407655	Method of inhibiting leukocytes with human CXC chemokine receptor 3 antibody
7402306	Cancer immunotherapy with semi-allogeneic cells
7402305	Polypeptides of the IFN.alpha.-21 gene
7399834	Anti-PRO1558 antibodies
7396687	Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
7396809	Methods and reagents for treating glucose metabolic disorders
7396827	Pharmaceutical compositions and treatment methods
7396904	Tumor-associated peptides binding to MHC-molecules
7396906	Pro4399 Polypeptides
7396907	Antibodies that bind PRO6182 polypeptides
7396916	Antibody to a polypeptide overexpressed in tumors
7399464	Polypeptides of the IFN.alpha.-7 gene
7399465	Pharmaceutical compositions for treating arthritis and inflammatory disease
7399583	Method for the identification of inhibitors of the binding of ARE-containing mRNA and a HuR protein
7407662	Modified viral particles with immunogenic properties and reduced lipid content
7407663	Modified immunodeficiency virus particles
7413869	Method for determining potency of antigenic presenting cell based vaccines
7414108	Composition and method for producing an immune response against tumor-related antigens
7414123	Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
7414170	Transgenic bovines capable of human antibody production
7416726	Enhancement of antibody-mediated immune responses
7416730	Derivatives of the IL-2 receptor gamma chain, their production and use
7416878	Immunogenic compositions including rough phenotype Brucella host strains and complementation DNA fragments
7416887	Methods for use of MPL ligands with primitive human stem cells
7417042	Compounds for enzyme inhibition
7417115	PRO6027 polypeptides
7413865	Diagnostic method for a transmissible spongiform encephalopathy or prion disease
7413733	Antigen transduced T cells used as a delivery system for antigens
7413575	Nanofibrous biocomposite prosthetic vascular graft
7407959	Cathepsin cysteine protease inhibitors
7408032	PRO1188 polypeptides
7408033	PRO5995 polypeptides
7408039	Kits for treatment of hematologic disorders
7408042	Anti-PRO6181 antibodies
7410656	Anti-cancer compounds
7410758	Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
7410773	Method of preparing an undifferentiated cell
7411040	PRO6182 polypeptides
7411047	PRO6097 antibodies
7417123	PRO4399 Antibodies

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.